What is Bliss GVS Pharma Limited (BLISSGVS) share price today?

Bliss GVS Pharma Limited (BLISSGVS) is listed on the NSE. Visit VestAI at https://www.vestai.io/stocks/BLISSGVS for the latest live price, technical analysis, and AI-powered insights.

How to analyse BLISSGVS stock?

VestAI provides comprehensive BLISSGVS stock analysis including RSI, MACD, Bollinger Bands, SMA trend, ROCE, debt-to-equity ratio, and smart money holdings by superstar investors.

What sector is Bliss GVS Pharma Limited in?

Bliss GVS Pharma Limited (BLISSGVS) is in the Healthcare sector, Pharmaceuticals industry on the NSE.

Bliss GVS Pharma Limited

Q: What is Bliss GVS Pharma Limited's Orion Score?

Bliss GVS Pharma Limited has an Orion Score of 65/100 (Watch) — a fundamentals-based quality & risk score. Bliss GVS Pharma Limited scores 65/100 (Watch) on the Orion Score — moderate business quality (64), moderate growth (60), strong balance-sheet safety (88) and fair valuation (42). A fundamentals-based quality & risk score, not a buy/sell recommendation.

BLISSGVS

NSE· Healthcare

₹505.95

-21.15 (-4.01%)

Updated 12:12 pm IST

52W Low · ₹118.0052W High · ₹553.00

Near 52W High

Market Cap

₹5570.37L Cr

Volume

6.35L

Prev Close

₹524.10

ISIN

INE416D01022

Orion Score

Fundamentals-based quality & risk · not a recommendation

65/100

Watch

Bliss GVS Pharma Limited scores 65/100 (Watch) on the Orion Score — moderate business quality (64), moderate growth (60), strong balance-sheet safety (88) and fair valuation (42). A fundamentals-based quality & risk score, not a buy/sell recommendation.

Quality

Growth

Safety

Value

Full Orion analysis

Risk checks

Profit converts to cash (CFO 1.4× PAT)
Low debt, comfortable interest cover
No distress, manipulation or dilution flags

Forensic accounting

Piotroski F 6/9Altman Z Safe(10.80)Beneish M Clean(-2.39)

Piotroski F = fundamental health (0–9, higher is better) · Altman Z = bankruptcy / distress risk · Beneish M = earnings-manipulation check

Technical / Momentum

Price Trend

69/100

Strong

Technical momentum companion — separate from the fundamentals-based Orion Score.

Unlock with Pro

Upgrade →

VestAI Stock Score

VALUATION

Low Debt

D/E 0.02x — lean balance sheet

QUALITY

Average

ROCE 12.7% — decent returns

MOMENTUM

No Data

RSI unavailable

Price Chart

SMA 20

SMA 50

SMA 200

Key Fundamentals

Q4 FY2026

P/E Ratio: 43.69
ROCE: 12.66%
ROE (1Y): 11.60%
D/E Ratio: 0.02x
OPM: 13.92%
TTM EPS: ₹12.00
Dividend Yield: 38.00%
Qtrly Sales: ₹256.99 Cr
Qtrly Profit: ₹35.58 Cr

Technical Signals

Quarterly Results

Revenue & Profit in ₹ Crores

Revenue Net Profit

Quarter	Revenue	Net Profit	OPM	EPS
Q4 2026	₹256.99	₹35.58	13.9%	₹3.27
Q3 2026	₹218.25	₹23.27	12.1%	₹2.14
Q2 2026	₹244.4	₹27.25	9.6%	₹2.54
Q1 2026	₹207.47	₹43.04	16.0%	₹4.04
Q4 2025	₹197.99	₹15.54	6.6%	₹1.46

Annual P&L

Revenue & Profit in ₹ Crores (Yearly)

Revenue Net Profit

Year	Revenue	Net Profit	EBITDA	OPM
FY 2026	₹927.11	₹129.13	₹235.08	14.1%
FY 2025	₹809.73	₹84.3	₹163.18	12.0%
FY 2024	₹765.91	₹75.45	₹148.81	17.6%
FY 2023	₹747.43	₹70.86	₹127.99	13.5%

Peer Comparison — Healthcare

Top companies in the same sector by market cap

Company	Mkt Cap	P/E	ROCE	ROE	D/E	OPM
BLISSGVS ★	₹5,570 Cr	43.69	12.66%	11.60%	0.02x	13.92%
SUNPHARMASun Pharmaceutical Industries	₹4,27,609 Cr	37.32	15.73%	14.72%	0.06x	18.90%
MAXHEALTHMax Healthcare Institute	₹95,110 Cr	66.21	11.94%	14.33%	0.32x	22.56%
AUROPHARMAAurobindo Pharma Limited	₹90,029 Cr	25.94	12.55%	9.93%	0.21x	15.11%
ABBOTINDIAAbbott India Limited	₹57,724 Cr	36.63	36.14%	34.46%	0.04x	27.01%
AJANTPHARMAjanta Pharma Limited	₹41,836 Cr	39.55	27.99%	25.39%	0.06x	51.40%

Balance Sheet

All values in ₹ Crores

Metric	FY 2025	FY 2024	FY 2023	FY 2022
Total Assets	₹1,300.84	₹1,211.59	₹1,156.85	₹1,108.75
Equity	₹1,050.38	₹967.19	₹883.9	₹818.7
Total Debt	₹88.1	₹99.84	₹101.9	₹109.39
Cash	₹23.79	₹23.14	₹24.96	₹21.92
Net Debt	₹47.18	₹64.67	₹73.11	₹83.04
Working Capital	₹654.79	₹653.47	₹504.11	₹543.77

Shareholding Pattern

Q1 FY2027

Promoter

60.18%

FII

3.61%

DII

2.96%

Public

33.25%

Quarter-over-Quarter Trend

Quarter	Promoter	FII	DII	Public
Q1 FY2027	60.18% ↓	3.61% ↓	2.96% ↓	33.25% ↑
Q4 FY2026	62.37% ↑	3.63% ↓	2.97% ↓	31.03% ↓
Q3 FY2026	35.36% ↓	14.54% ↑	5.78% ↓	44.32% ↓
Q2 FY2026	35.39% ↓	13.27% ↑	5.98% ↓	45.36%
Q1 FY2026	35.44% ↑	12.65% ↓	6.54%	45.37% ↑
Q4 FY2025	35.29% ↑	13.18% ↓	6.55%	44.98% ↑
Q3 FY2025	35.1% ↑	13.51% ↑	6.55%	44.84% ↓
Q2 FY2025	34.82%	12.13%	6.56%	46.49%

Corporate Actions

Ex-Date	Action	Details
2026-07-08	DIVIDEND	Dividend - Re 1 Per Share
2026-02-18	DIVIDEND	Interim Dividend - Re 0.50 Per Share

Funds Holding This Stock

2 mutual fund schemes

Union Active Momentum Fund Direct GrowthUNION_KBC

3.11%

₹15 Cr

Bandhan BSE Healthcare Index Fund Direct GrowthIDFC

0.19%

₹0 Cr

Analyse BLISSGVS with Orion AI

Ask: "Is Bliss GVS Pharma Limited stock a good buy right now?" — Get RSI, MACD, ROCE + AI recommendation

Analyse with Orion

Want more insights like this?

Get free stock analysis, market insights, and investment ideas delivered to your inbox.

No spam. Unsubscribe anytime.

About Bliss GVS Pharma Limited (BLISSGVS) Stock

Bliss GVS Pharma Limited is listed on the NSE under the Healthcare sector, Pharmaceuticals industry. ISIN: INE416D01022. Track live share price, technical analysis, RSI, MACD, PE ratio, and smart money holdings on VestAI — India's AI-powered stock analysis platform.